Well-Tempered Metadynamics Simulations Combined with Free Energy Landscape Analysis Uncover the Conformational Transition Pathway of the DYG Motif in LRRK2
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.5c00054 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Xiaoqing Gong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Applied Sciences, Macao Polytechnic University, Macao 999078, China. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Fundo para o Desenvolvimento das Ci?ncias e da Tecnologia, Macao Polytechnic University.
Abstract (Originalsprache)
Leucine-rich repeat kinase 2 (LRRK2) is one of the most promising targets for the treatment of Parkinson's Disease. The activation of LRRK2 is regulated by the conserved Asp-Tyr-Gly (DYG) motif of the activation loop. Understanding the flipping process of the DYG motif from active to inactive is crucial for the regulation of LRRK2 kinase catalytic activity. Typically, type I inhibitors stabilize LRRK2 in the active conformation, while type II inhibitors favor the inactive state. To investigate the DYG-flipping mechanism, we performed well-tempered metadynamics simulations on LRRK2 in three distinct states: (1) the apo (ligand-free) state, (2) the type I inhibitor-bound state (DNL201), and (3) the type II inhibitor-bound state (rebastinib). The two-dimensional free energy landscape of DYG flipping in LRRK2 revealed transition pathways between the active ("DYG-in") and inactive ("DYG-out") states. Two distinct pathways were identified, which were differentiated by the orientation of Y2018. In the apo system, the DYG motif undergoes an upward flipping motion. Notably, type I inhibitor DNL201 stabilizes LRRK2 in the DYG-in active conformation, whereas type II inhibitor rebastinib promotes a downward flip into the DYG-out inactive state. These findings elucidate the conformational dynamics of LRRK2 in both unbound and ligand-regulated states as well as the mechanistic details of DYG motif flipping. Our study provides critical structural insights for targeted inhibition of LRRK2 kinase activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Applied Sciences, Macao Polytechnic University, Macao 999078, China.
- State Key Laboratory of Chinese Medicine Modernization, Innovation Center of Yangtze River Delta, Zhejiang University, Jiaxing 314100, China.
ORCID-Profile: Qianqian Zhang, Xiaojun Yao, Huanxiang Liu
Förderung
- Fundo para o Desenvolvimento das Ci?ncias e da Tecnologia
- Macao Polytechnic University
Zitieren
APA
Gong, X., Tan, S., Wang, L., Tian, Y., Zhang, Q., Tong, H. H. Y., Yao, X., & Liu, H. (2025). Well-Tempered Metadynamics Simulations Combined with Free Energy Landscape Analysis Uncover the Conformational Transition Pathway of the DYG Motif in LRRK2. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00054
Vancouver
Gong X, Tan S, Wang L, Tian Y, Zhang Q, Tong HHY, et al. Well-Tempered Metadynamics Simulations Combined with Free Energy Landscape Analysis Uncover the Conformational Transition Pathway of the DYG Motif in LRRK2. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00054
BibTeX
@article{Gong2025,
author = {Gong, Xiaoqing and Tan, Shuoyan and Wang, Lingling and Tian, Yanan and Zhang, Qianqian and Tong, Henry H Y and Yao, Xiaojun and Liu, Huanxiang},
title = {Well-Tempered Metadynamics Simulations Combined with Free Energy Landscape Analysis Uncover the Conformational Transition Pathway of the DYG Motif in LRRK2},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.5c00054}
}
EUVIMED